Those of us involved in personalized or precision medicine (PM) understand the huge impact it should have on everyone’s life and healthcare in general if all the stakeholders work for the good of the patient. This ideal represents the end of the journey but inevitably we are focussed on the [...]
The term competitive intelligence conjures up images of spies, undercover work and self-destructing messages. In some companies the concept may be so under the radar, or more likely underfunded, as to be almost a genuine secret, but for many pharma companies it plays a crucial role in their [...]
We asked four senior executives in the pharma and diagnostic industry to come up with a value on how much it would cost to launch and commercialize a novel diagnostic test. Here’s what they came up with. CDx Launch Cost Create bar [...]
Access to diagnostic tests and the subsequent reimbursement is an issue affecting all stakeholders in the fast evolving personalized medicine space. It’s an intricate web woven by drug companies, payers, insurance giants, laboratories and national health organizations. And once you think you have [...]
The product launch is a moment of truth when it comes to the longevity of any pharmaceutical company. If a company manages a launch well, all of its recent shortcomings are forgiven and even patent cliffs become less scary. For the companies who will lead the way in the next century, pharmaceutical [...]